Current status and future prospect of surgical treatment for pancreatic cancer.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

11 citing papers in PubMed.

1. Examining health system stakeholder-reported barriers and solutions to foregut cancer care.American journal of surgery · 2026
   Article
2. Developing Patient-Derived 3D-Bioprinting models of pancreatic cancer.Journal of advanced research · 2025
   Article
3. Identification of exosome-related genes associated with prognosis and immune infiltration features in pancreatic cancer.Discover oncology · 2025
   Article
4. Laparoscopic radical distal pancreatectomy with portal venous tumor thrombectomy for the treatment of pancreatic acinar cell carcinoma after neoadjuvant chemotherapy.Hepatobiliary surgery and nutrition · 2023
   Article
5. Exosome and lipid metabolism-related genes in pancreatic adenocarcinoma: a prognosis analysis.Aging · 2023
   Article
6. Revolutionizing preclinical research for pancreatic cancer: the potential of 3D bioprinting technology for personalized therapy.Hepatobiliary surgery and nutrition · 2023
   Article
7. The management strategy of pancreatic cancer in the era of systemic therapy-"Surgery First" or "Surgery Last"?Hepatobiliary surgery and nutrition · 2022
   Article
8. Development and validation of prognostic and diagnostic model for pancreatic ductal adenocarcinoma based on scRNA-seq and bulk-seq datasets.Human molecular genetics · 2022
   Article
9. The Role of Exosomes in Pancreatic Cancer From Bench to Clinical Application: An Updated Review.Frontiers in oncology · 2021
   Review
10. Large-Section Histopathology Can Better Indicate the Immune Microenvironment and Predict the Prognosis of Pancreatic Ductal Adenocarcinoma Than Small-Section Histopathology.Frontiers in oncology · 2021
    Article
11. Predicting early recurrence for resected pancreatic ductal adenocarcinoma: a multicenter retrospective study in China.American journal of cancer research · 2021
    Article

Corrections and comments

• Commented on by
  Laparoscopic radical distal pancreatectomy with portal venous tumor thrombectomy for the treatment of pancreatic acinar cell carcinoma after neoadjuvant chemotherapy.2023

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.